更新された供給不足状況を示しています。
ある時点での供給不足の全体的状況は「供給関連情報」に定期的にアップします。
米国
- 2025.04.27
- 2025.04.27
April 25, 2025
Liraglutide Injection (Currently In Shortage)April 24, 2025
Topiramate Capsule, Extended Release (Discontinuation)April 23, 2025
Baclofen Tablet (Discontinuation)April 22, 2025
Oxaliplatin Injection (Discontinuation) - 2025.04.21
- 2025.04.21
April 14, 2025
- Adalimumab-adaz Injection (Discontinuation)
- 2025.04.14
- 2025.04.14
April 10, 2025
- Tamsulosin Hydrochloride Capsule (Discontinuation)
April 7, 2025
- Haloperidol Decanoate Injection (Discontinuation)
- 2025.04.07
- 2025.04.07
April 2, 2025
- Liraglutide Injection (Currently In Shortage)
April 1, 2025
- Zileuton Tablet (Discontinuation)
カナダ
カナダの情報はありません。
オーストラリア
- 2025.04.27
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated oxytocin Injection, solution 10 IU/mL Discontinued Reduction in supply until supply is exhausted Unexpected increase in consumer demand 24/04/2025 oxytocin Injection, solution 5 IU/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/04/2025 clonazepam Oral Liquid, solution 2.5 mg/mL Current Limited Availability Manufacturing 24/04/2025 indapamide hemihydrate Tablet, modified release 1.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/04/2025 pentetic acid Injection, powder for 5 mg Current Unavailable Manufacturing 24/04/2025 sodium pyrophosphate Injection, powder for 30 mg Current Unavailable Manufacturing 24/04/2025 medronic acid Injection, powder for 10 mg Current Unavailable Manufacturing 24/04/2025 sodium fluoride Injection, concentrated 1 mg/mL Current Unavailable Manufacturing 24/04/2025 trimethoprim~sulfamethoxazole Tablet 160 mg~800 mg Current Limited Availability Unexpected increase in consumer demand 24/04/2025 oxytocin Injection, solution 10 IU Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 24/04/2025 bisoprolol fumarate Tablet 2.5 mg Resolved Available Manufacturing 24/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Anticipated Available Manufacturing 24/04/2025 montelukast sodium Tablet, chewable 5.2 mg Anticipated Available Unexpected increase in consumer demand 24/04/2025 azithromycin dihydrate Tablet, film coated 524.05 mg Current Unavailable Manufacturing 24/04/2025 naproxen Oral Liquid, suspension 25 mg/mL Current Limited Availability Manufacturing 24/04/2025 trandolapril Capsule, hard 1 mg Current Unavailable Manufacturing 24/04/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 24/04/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 24/04/2025 quetiapine fumarate Tablet, modified release 345.39 mg Anticipated Available Unexpected increase in consumer demand 24/04/2025 oxytocin Injection, solution 5 IU/mL Current Limited Availability Unexpected increase in consumer demand 24/04/2025 oxytocin Injection, solution 10 IU/mL Anticipated Available Manufacturing 24/04/2025 celecoxib Capsule, hard 100 mg Resolved Available Manufacturing 24/04/2025 escitalopram oxalate Tablet, film coated 25.47 mg Resolved Available Manufacturing 24/04/2025 bosentan monohydrate Tablet, film coated 129.08 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/04/2025 betahistine dihydrochloride Tablet 16 mg Resolved Available Manufacturing 24/04/2025 tadalafil Tablet, film coated 10 mg Resolved Available Manufacturing 24/04/2025 tadalafil Tablet, film coated 20 mg Resolved Available Manufacturing 24/04/2025 metformin hydrochloride Tablet, film coated 500 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 24/04/2025 busulfan Injection, concentrated 60 mg Current Limited Availability Manufacturing 24/04/2025 risperidone Tablet, film coated 3 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 24/04/2025 nebivolol hydrochloride Tablet 5.45 mg Current Unavailable Manufacturing 24/04/2025 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 24/04/2025 sitagliptin hydrochloride monohydrate Tablet, film coated 56.69 mg Current Unavailable Manufacturing 24/04/2025 sildenafil citrate Tablet, film coated 70.24 mg Current Unavailable Unexpected increase in consumer demand 24/04/2025 melatonin Capsule, hard 3 mg Resolved Available Unexpected increase in consumer demand 24/04/2025 cabergoline Tablet, uncoated 1 mg Anticipated Available Manufacturing 24/04/2025 balsalazide sodium Capsule 750 mg Resolved Available Manufacturing 24/04/2025 gefitinib Tablet, film coated 250 mg Resolved Available Commercial Changes / Commercial viability 24/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/04/2025 fentanyl Drug delivery system, transdermal 4.2 mg Discontinued Unavailable Manufacturing 23/04/2025 fentanyl Drug delivery system, transdermal 8.4 mg Discontinued Unavailable Manufacturing 23/04/2025 fentanyl Drug delivery system, transdermal 12.6 mg Discontinued Unavailable Manufacturing 23/04/2025 fentanyl Drug delivery system, transdermal 16.8 mg Discontinued Unavailable Manufacturing 23/04/2025 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Limited Availability Unexpected increase in consumer demand 23/04/2025 fentanyl Drug delivery system, transdermal 2.1 mg Discontinued Unavailable Manufacturing 23/04/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Current Limited Availability Manufacturing 23/04/2025 amiodarone hydrochloride Injection, solution 150 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Anticipated Available Manufacturing 23/04/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Anticipated Available Manufacturing 23/04/2025 risedronate sodium hemipentahydrate Tablet, film coated 173.4 mg Anticipated Available Manufacturing 23/04/2025 montelukast sodium Tablet, chewable 5.2 mg Resolved Available Manufacturing 23/04/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 23/04/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 23/04/2025 isotretinoin Capsule, soft 10 mg Current Unavailable Manufacturing 23/04/2025 propofol Injection, emulsion 10 g/L Current Limited Availability Transport / Logistic issues / Storage capacity issues 23/04/2025 candesartan cilexetil Tablet, uncoated 16 mg Anticipated Available Manufacturing 23/04/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Unavailable Unexpected increase in consumer demand 23/04/2025 estradiol~dydrogesterone Tablet, film coated 1 mg~10 mg Current Limited Availability Manufacturing 23/04/2025 acarbose Tablet 100 mg Anticipated Available Manufacturing 23/04/2025 flecainide acetate Tablet, uncoated 100 mg Current Limited Availability Manufacturing 23/04/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Anticipated Available Manufacturing 23/04/2025 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 2 mg/mL Anticipated Available Transport / Logistic issues / Storage capacity issues 23/04/2025 teriflunomide Tablet, film coated 14 mg Current Limited Availability Manufacturing 23/04/2025 olanzapine Tablet, uncoated 5 mg Current Limited Availability Manufacturing 23/04/2025 montelukast sodium Tablet, chewable 5.2 mg Current Unavailable Manufacturing 23/04/2025 methylphenidate hydrochloride Capsule, hard 40 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 methylphenidate hydrochloride Capsule, hard 20 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 methylphenidate hydrochloride Capsule, hard 30 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 methylphenidate hydrochloride Capsule, hard 10 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 methylphenidate hydrochloride Capsule, hard 60 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 23/04/2025 bicisate dihydrochloride Injection, powder for .9 mg Resolved Available Manufacturing 23/04/2025 estradiol hemihydrate Tablet, film coated 2.06 mg Resolved Available Manufacturing 23/04/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Anticipated Available Manufacturing 23/04/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 23/04/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Anticipated Available Manufacturing 23/04/2025 gentamicin Injection, solution 80 mg Current Unavailable Manufacturing 22/04/2025 acetylcysteine Injection, concentrated 2 g Resolved Available Manufacturing 22/04/2025 fentanyl Drug delivery system, transdermal 16.8 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 22/04/2025 azithromycin dihydrate Tablet, film coated 524.1 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/04/2025 vincristine sulfate Injection, solution 1 mg/mL Anticipated Available Manufacturing 22/04/2025 bisoprolol fumarate Tablet 10 mg Resolved Available Manufacturing 22/04/2025 valsartan~hydrochlorothiazide Tablet, film coated 320 mg~25 mg Current Limited Availability Manufacturing 22/04/2025 sildenafil citrate Tablet, film coated 28.1 mg Resolved Available Manufacturing 22/04/2025 risperidone Tablet, film coated 1 mg Resolved Available Unexpected increase in consumer demand 22/04/2025 capecitabine Tablet, film coated 500 mg Current Unavailable Manufacturing 22/04/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Current Limited Availability Manufacturing 22/04/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~5.198 mg Resolved Available Manufacturing 22/04/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 22/04/2025 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 22/04/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 22/04/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 22/04/2025 avibactam sodium~ceftazidime pentahydrate Injection, powder for 543.5 mg~2329.7 mg Anticipated Available Unexpected increase in consumer demand 22/04/2025 carmustine~ethanol absolute Diluent, not applicable~Injection, powder for 100 mg~3 mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/04/2025 daptomycin Injection, powder for 500 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 22/04/2025 daptomycin Inhalation, powder for 350 mg Current Unavailable Manufacturing 22/04/2025 levothyroxine sodium Tablet 75 microgram Current Unavailable Manufacturing 22/04/2025 lorazepam Tablet 2.5 mg Resolved Available Manufacturing 22/04/2025 gentamicin sulfate Injection, solution 135.6 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 22/04/2025 cytarabine Injection, solution 100 mg/mL Anticipated Available Manufacturing 22/04/2025 estradiol~norethisterone acetate Drug delivery system, transdermal .512 mg~4.8 mg Current Unavailable Manufacturing 22/04/2025 hydrochlorothiazide~quinapril hydrochloride Tablet, film coated 12.5 mg~10.832 mg Current Unavailable Manufacturing 22/04/2025 quinapril hydrochloride~hydrochlorothiazide Tablet, film coated 21.664 mg~12.5 mg Current Unavailable Manufacturing 22/04/2025 - 2025.04.21
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 18/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 18/04/2025 gabapentin Capsule, hard 300 mg Current Limited Availability Manufacturing 17/04/2025 zolpidem tartrate Tablet, film coated 10 mg Resolved Available Manufacturing 17/04/2025 midazolam Injection, solution 5 mg/mL Anticipated Available Manufacturing 17/04/2025 venlafaxine Capsule, modified release 75 mg Current Limited Availability Manufacturing 17/04/2025 venlafaxine Capsule, modified release 150 mg Current Limited Availability Manufacturing 17/04/2025 clomipramine hydrochloride Tablet, film coated 25 mg Resolved Available Manufacturing 17/04/2025 losartan potassium Tablet, film coated 50 mg Current Limited Availability Manufacturing 17/04/2025 losartan potassium Tablet, film coated 25 mg Current Limited Availability Manufacturing 17/04/2025 mirtazapine Tablet, film coated 45 mg Current Unavailable Manufacturing 17/04/2025 donepezil hydrochloride Tablet, film coated 10 mg Current Unavailable Manufacturing 17/04/2025 rocuronium bromide Injection, solution 50 mg Anticipated Available Manufacturing 17/04/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 17/04/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Current Unavailable Transport / Logistic issues / Storage capacity issues 17/04/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet 6.944 mg~40 mg~12.5 mg Current Limited Availability Manufacturing 17/04/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~41.583 mg Current Limited Availability Manufacturing 17/04/2025 ezetimibe~rosuvastatin calcium Tablet~Tablet, film coated 10 mg~10.396 mg Current Unavailable Manufacturing 17/04/2025 metoprolol succinate Tablet, modified release 95 mg Current Limited Availability Manufacturing 17/04/2025 metoprolol succinate Tablet, modified release 47.5 mg Current Unavailable Manufacturing 17/04/2025 metoprolol succinate Tablet, modified release 190 mg Current Unavailable Manufacturing 17/04/2025 metoprolol succinate Tablet, modified release 23.75 mg Current Limited Availability Manufacturing 17/04/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 17/04/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, multilayer 10 mg~86.8 mg Current Limited Availability Manufacturing 17/04/2025 esomeprazole Capsule, enteric 20 mg Current Limited Availability Manufacturing 17/04/2025 anastrozole Tablet, film coated 1 mg Current Unavailable Manufacturing 17/04/2025 atorvastatin calcium trihydrate Tablet, film coated 43.376 mg Current Unavailable Manufacturing 17/04/2025 spironolactone Tablet, uncoated 25 mg Current Limited Availability Manufacturing 17/04/2025 piroxicam Capsule, hard 10 mg Discontinued Unavailable Commercial Changes / Commercial viability 17/04/2025 piroxicam Capsule, hard 20 mg Discontinued Unavailable Commercial Changes / Commercial viability 17/04/2025 spironolactone Tablet, film coated 100 mg Anticipated Available Manufacturing 17/04/2025 iopromide Injection, solution 498.72 mg/mL Current Unavailable Manufacturing 17/04/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Anticipated Available Manufacturing 17/04/2025 primidone Tablet, uncoated 250 mg Current Unavailable Manufacturing 16/04/2025 olanzapine Tablet, film coated 7.5 mg Resolved Available Manufacturing 16/04/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Resolved Available Unexpected increase in demand due to other sponsors unable to supply 16/04/2025 risperidone Tablet, film coated 1 mg Current Limited Availability Unexpected increase in consumer demand 16/04/2025 risperidone Tablet, film coated .5 mg Current Limited Availability Manufacturing 16/04/2025 duloxetine hydrochloride Capsule, enteric 67.3 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 16/04/2025 pramipexole dihydrochloride monohydrate Tablet .25 mg Anticipated Available Unexpected increase in consumer demand 16/04/2025 fenofibrate Tablet 48 mg Resolved Available Manufacturing 16/04/2025 betahistine dihydrochloride Tablet 16 mg Current Unavailable Manufacturing 16/04/2025 clonidine hydrochloride Tablet 100 microgram Resolved Available Manufacturing 16/04/2025 anastrozole Tablet, film coated 1 mg Current Limited Availability Manufacturing 16/04/2025 mercaptopurine monohydrate Tablet 50 mg Anticipated Available Manufacturing 16/04/2025 dexmedetomidine hydrochloride Injection, concentrated 118 microgram/mL Anticipated Available Manufacturing 16/04/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 16/04/2025 naloxone hydrochloride dihydrate Spray, nasal 2.2 mg/actuation Current Limited Availability Transport / Logistic issues / Storage capacity issues 16/04/2025 nebivolol hydrochloride Tablet 10.9 mg Resolved Available Manufacturing 16/04/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 16/04/2025 bortezomib Injection, solution 3.5 mg Anticipated Available Manufacturing 16/04/2025 melatonin Capsule, hard 3 mg Current Unavailable Unexpected increase in consumer demand 16/04/2025 carbidopa monohydrate~levodopa Tablet, uncoated 26.9 mg~100 mg Current Limited Availability Manufacturing 16/04/2025 balsalazide sodium Capsule 750 mg Current Limited Availability Manufacturing 16/04/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Resolved Available Unexpected increase in consumer demand 16/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 15/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Resolved Available Transport / Logistic issues / Storage capacity issues 15/04/2025 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Unavailable Manufacturing 15/04/2025 amlodipine besilate Tablet, uncoated 7 mg Resolved Available Manufacturing 15/04/2025 Hepatitis a virus antigen~Hepatitis B surface antigen recombinant Injection, suspension 720 ELISA unit/mL~20 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/04/2025 risedronate sodium Tablet, film coated 35 mg Resolved Available Manufacturing 15/04/2025 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 15/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.9 mg Anticipated Available Manufacturing 15/04/2025 propranolol hydrochloride Tablet, film coated 40 mg Current Limited Availability Manufacturing 15/04/2025 perindopril erbumine Tablet 8 mg Anticipated Available Manufacturing 15/04/2025 sildenafil citrate Tablet, film coated 28.1 mg Current Limited Availability Manufacturing 15/04/2025 azithromycin dihydrate Tablet, film coated 524 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 15/04/2025 hydromorphone hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 15/04/2025 ivabradine hydrochloride Tablet, film coated 8.085 mg Current Limited Availability Manufacturing 15/04/2025 acamprosate calcium Tablet, enteric coated 333 mg Current Limited Availability Manufacturing 15/04/2025 fluconazole Capsule, hard 200 mg Resolved Available Manufacturing 15/04/2025 ropinirole hydrochloride Tablet, film coated .57 mg Current Limited Availability Manufacturing 15/04/2025 Pegfilgrastim Injection, solution 6 mg Current Limited Availability Manufacturing 15/04/2025 tamoxifen citrate Tablet 30.34 mg Current Limited Availability Manufacturing 15/04/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 15/04/2025 rivaroxaban Tablet, film coated 10 mg Resolved Available Manufacturing 15/04/2025 podophyllotoxin Solution 5 mg/mL Discontinued Reduction in supply until supply is exhausted Manufacturing 15/04/2025 deferasirox Tablet, film coated 360 mg Resolved Available Manufacturing 15/04/2025 azithromycin dihydrate Tablet, film coated 524 mg Resolved Available Unexpected increase in consumer demand 15/04/2025 ketamine hydrochloride Injection, solution 115.3 mg/mL Resolved Available Manufacturing 15/04/2025 dydrogesterone~estradiol Tablet, film coated 10 mg~2 mg Current Limited Availability Manufacturing 15/04/2025 alprostadil Injection, powder for 20 microgram/mL Current Limited Availability Unexpected increase in consumer demand 15/04/2025 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 14/04/2025 risperidone Tablet, film coated 3 mg Resolved Available Manufacturing 14/04/2025 risperidone Tablet, film coated 4 mg Resolved Available Manufacturing 14/04/2025 risperidone Tablet, film coated 1 mg Resolved Available Manufacturing 14/04/2025 risperidone Tablet, film coated .5 mg Resolved Available Manufacturing 14/04/2025 risperidone Tablet, film coated 2 mg Resolved Available Manufacturing 14/04/2025 pramipexole dihydrochloride monohydrate Tablet .125 mg Resolved Available Manufacturing 14/04/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 14/04/2025 methotrexate Injection, solution 100 mg/mL Current Unavailable Manufacturing 14/04/2025 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 4 mg Resolved Available Manufacturing 14/04/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 14/04/2025 sildenafil citrate Tablet, film coated 140.48 mg Current Limited Availability Manufacturing 14/04/2025 fentanyl citrate Injection, solution 785 microgram Anticipated Available Manufacturing 14/04/2025 flecainide acetate Tablet, uncoated 100 mg Current Limited Availability Manufacturing 14/04/2025 propofol Injection, emulsion 10 mg/mL Current Limited Availability Manufacturing 14/04/2025 clarithromycin Tablet, film coated 250 mg Resolved Available Manufacturing 14/04/2025 - 2025.04.14
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated norethisterone Tablet, uncoated 350 microgram Current Limited Availability Unexpected increase in consumer demand 11/04/2025 tramadol hydrochloride Capsule 50 mg Current Limited Availability Manufacturing 11/04/2025 sumatriptan succinate Tablet, film coated 140 mg Current Unavailable Manufacturing 11/04/2025 metformin hydrochloride Tablet, film coated 850 mg Current Limited Availability Manufacturing 11/04/2025 ramipril Capsule, hard 5 mg Current Limited Availability Manufacturing 11/04/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Anticipated Available Manufacturing 11/04/2025 metformin hydrochloride Tablet, film coated 500 mg Current Unavailable Manufacturing 11/04/2025 sulfamethoxazole~trimethoprim Injection, concentrated 80 mg/mL~16 mg/mL Current Limited Availability Manufacturing 11/04/2025 fluorouracil Injection, solution 5000 mg Current Unavailable Unexpected increase in consumer demand 11/04/2025 perindopril erbumine Tablet 8 mg Anticipated Available Manufacturing 11/04/2025 lansoprazole Tablet, orally disintegrating 15 mg Current Limited Availability Manufacturing 11/04/2025 risperidone Tablet, film coated .5 mg Anticipated Available Manufacturing 11/04/2025 capecitabine Tablet, film coated 500 mg Current Unavailable Manufacturing 11/04/2025 metoprolol succinate Tablet, modified release 23.75 mg Current Limited Availability Manufacturing 11/04/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 11/04/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 11/04/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 11/04/2025 metformin hydrochloride Tablet, film coated 1000 mg Current Unavailable Manufacturing 11/04/2025 isavuconazonium sulfate Capsule, hard 186.3 mg Anticipated Available Manufacturing 11/04/2025 deferasirox Tablet, film coated 360 mg Anticipated Available Manufacturing 11/04/2025 atorvastatin calcium trihydrate Tablet, film coated 10.844 mg Current Limited Availability Manufacturing 11/04/2025 atorvastatin calcium trihydrate Tablet, film coated 86.751 mg Current Limited Availability Manufacturing 11/04/2025 Fremanezumab Injection, solution 225 mg Anticipated Available Unexpected increase in consumer demand 11/04/2025 perindopril arginine Tablet, film coated 2.5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/04/2025 perindopril arginine Tablet, film coated 5 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/04/2025 perindopril arginine Tablet, film coated 10 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 11/04/2025 cisplatin Injection, solution 1 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 11/04/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 11/04/2025 salbutamol sulfate Inhalation, conventional 3 mg Current Unavailable Manufacturing 10/04/2025 zolpidem tartrate Tablet, film coated 10 mg Current Limited Availability Manufacturing 10/04/2025 adrenaline (epinephrine) acid tartrate~lidocaine hydrochloride monohydrate Injection, solution 22.7 microgram/mL~21.3 mg/mL Current Unavailable Manufacturing 10/04/2025 clomipramine hydrochloride Tablet, film coated 25 mg Current Limited Availability Manufacturing 10/04/2025 hydroxocobalamin chloride Injection, solution 1 mg/mL Resolved Available Manufacturing 10/04/2025 letrozole Tablet, film coated 2.5 mg Current Limited Availability Manufacturing 10/04/2025 propofol Injection, emulsion 10 g/L Resolved Available Transport / Logistic issues / Storage capacity issues 10/04/2025 capecitabine Tablet, film coated 500 mg Current Limited Availability Unexpected increase in consumer demand 10/04/2025 Follitropin alfa Injection, solution 75 IU Current Unavailable Manufacturing 10/04/2025 Follitropin alfa Injection, solution 150 IU Current Unavailable Manufacturing 10/04/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 10/04/2025 hydrocortisone Tablet, uncoated 4 mg Resolved Available Manufacturing 10/04/2025 hydrocortisone Tablet, uncoated 20 mg Current Limited Availability Manufacturing 10/04/2025 celecoxib Capsule, hard 100 mg Current Unavailable Manufacturing 10/04/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 10/04/2025 methotrexate Tablet 2.5 mg Resolved Available Manufacturing 10/04/2025 naproxen Tablet, uncoated 250 mg Anticipated Available Manufacturing 10/04/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 10/04/2025 tobramycin Injection, solution 40 mg/mL Resolved Available Unexpected increase in demand due to other sponsors unable to supply 10/04/2025 citalopram hydrobromide Tablet, film coated 49.96 mg Current Limited Availability Manufacturing 10/04/2025 fenofibrate Tablet, film coated 145 mg Resolved Available Manufacturing 9/04/2025 clonazepam Oral Liquid, solution 2.5 mg/mL Anticipated Available Manufacturing 9/04/2025 vinblastine sulfate Injection, solution 1 mg/mL Resolved Available Manufacturing 9/04/2025 timolol maleate Eye Drops, solution 6.83 mg/mL Current Limited Availability Commercial Changes / Commercial viability 9/04/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 41.363 mg~10 mg Resolved Available Manufacturing 9/04/2025 doxepin hydrochloride Capsule, hard 11.3 mg Resolved Available Manufacturing 9/04/2025 quinagolide hydrochloride Tablet, uncoated .0819 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 9/04/2025 timolol maleate Eye Drops, solution 6.84 mg/mL Current Limited Availability Commercial Changes / Commercial viability 9/04/2025 dorzolamide hydrochloride Eye Drops, solution 22.26 mg/mL Current Limited Availability Unexpected increase in consumer demand 9/04/2025 primidone Tablet, uncoated 250 mg Current Limited Availability Manufacturing 8/04/2025 lidocaine hydrochloride~adrenaline (epinephrine) acid tartrate Injection, solution 10 mg/mL~9.1 microgram/mL Resolved Available Commercial Changes / Commercial viability 8/04/2025 methylphenidate hydrochloride Capsule, modified release 10 mg Anticipated Available Manufacturing 8/04/2025 naproxen Oral Liquid, suspension 25 mg/mL Anticipated Available Manufacturing 8/04/2025 paclitaxel Injection, concentrated 300 mg Current Limited Availability Manufacturing 8/04/2025 prilocaine hydrochloride~felypressin Injection, solution 30 mg/mL~.54 microgram/mL Current Unavailable Manufacturing 8/04/2025 pemetrexed disodium Injection, powder for 551.4 mg Current Limited Availability Manufacturing 8/04/2025 methylphenidate hydrochloride Capsule, modified release 60 mg Anticipated Available Manufacturing 8/04/2025 metformin hydrochloride Tablet, film coated 1000 mg Resolved Available Manufacturing 8/04/2025 mesalazine Tablet, enteric coated 250 mg Current Unavailable Manufacturing 8/04/2025 busulfan Injection, concentrated 60 mg Anticipated Available Manufacturing 8/04/2025 enoxaparin sodium Injection, solution 80 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 8/04/2025 methylphenidate hydrochloride Capsule, modified release 20 mg Anticipated Available Manufacturing 8/04/2025 methylphenidate hydrochloride Capsule, modified release 30 mg Anticipated Available Manufacturing 8/04/2025 methylphenidate hydrochloride Capsule, modified release 40 mg Anticipated Available Manufacturing 8/04/2025 metformin hydrochloride Tablet, film coated 500 mg Resolved Available Manufacturing 8/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 7/04/2025 salbutamol sulfate Inhalation, conventional 6 mg Current Unavailable Manufacturing 7/04/2025 methylphenidate hydrochloride Tablet, uncoated 10 mg Anticipated Available Transport / Logistic issues / Storage capacity issues 7/04/2025 oxytocin Injection, solution 10 IU/mL Current Limited Availability Unexpected increase in consumer demand 7/04/2025 buprenorphine hydrochloride Injection, solution 324 microgram/mL Current Unavailable Manufacturing 7/04/2025 propranolol hydrochloride Tablet, film coated 40 mg Anticipated Available Manufacturing 7/04/2025 metronidazole Tablet, uncoated 400 mg Current Limited Availability Manufacturing 7/04/2025 escitalopram oxalate Tablet, film coated 25.548 mg Current Limited Availability Manufacturing 7/04/2025 dulaglutide Injection, solution 1.5 mg Current Limited Availability Manufacturing 7/04/2025 flecainide acetate Tablet, uncoated 50 mg Current Unavailable Manufacturing 7/04/2025 amiodarone hydrochloride Injection, solution 150 mg Current Unavailable Manufacturing 7/04/2025 citalopram hydrobromide Tablet, film coated 49.98 mg Anticipated Available Manufacturing 7/04/2025 ezetimibe Tablet, uncoated 10 mg Resolved Available Unexpected increase in consumer demand 7/04/2025 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~12.5 mg Current Unavailable Manufacturing 7/04/2025 irbesartan~hydrochlorothiazide Tablet, film coated 300 mg~25 mg Current Unavailable Manufacturing 7/04/2025 hydrochlorothiazide~olmesartan medoxomil Tablet 25 mg~40 mg Current Unavailable Manufacturing 7/04/2025 dasatinib Tablet, film coated 20 mg Resolved Available Unexpected increase in consumer demand 7/04/2025 pegaspargase Solution, powder for 750 U/mL Current Limited Availability Manufacturing 7/04/2025 risperidone Tablet, film coated 2 mg Resolved Available Manufacturing 7/04/2025 risperidone Tablet, film coated 4 mg Resolved Available Manufacturing 7/04/2025 latanoprost~timolol maleate Eye Drops, solution .05 mg/mL~6.83 mg/mL Resolved Available Manufacturing 7/04/2025 atorvastatin calcium trihydrate~ezetimibe Tablet, film coated 82.725 mg~10 mg Current Unavailable Manufacturing 7/04/2025 potassium chloride Injection, concentrated 75 mg/mL Current Unavailable Commercial Changes / Commercial viability 7/04/2025 ethanol absolute~carmustine Diluent, not applicable~Injection, powder for 3 mL~100 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 7/04/2025 nitrofurantoin Capsule, hard 100 mg Current Limited Availability Manufacturing 7/04/2025 alprazolam Tablet, uncoated 2 mg Current Limited Availability Manufacturing 7/04/2025 mirtazapine Tablet, film coated 30 mg Current Limited Availability Manufacturing 7/04/2025 - 2025.04.07
Active ingredients Dosage form Quantity of active ingredients Shortage status Availability Reason Last updated flecainide acetate Injection, solution 10 mg/mL Current Unavailable Manufacturing 4/04/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Manufacturing 4/04/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 1200000 USP Unit Anticipated Available Manufacturing 4/04/2025 olanzapine Tablet, film coated 10 mg Current Limited Availability Manufacturing 4/04/2025 midazolam Injection, solution 5 mg Current Limited Availability Manufacturing 4/04/2025 glyceryl trinitrate Injection, concentrated 50 mg Resolved Available Manufacturing 4/04/2025 Belimumab Injection, powder for 120 mg Resolved Available Manufacturing 4/04/2025 pramipexole dihydrochloride monohydrate Tablet 1 mg Current Unavailable Manufacturing 4/04/2025 montelukast sodium Tablet, film coated 10.4 mg Anticipated Available Manufacturing 4/04/2025 praziquantel Tablet, film coated 600 mg Discontinued Reduction in supply until supply is exhausted Manufacturing 4/04/2025 naproxen Oral Liquid, suspension 25 mg/mL Anticipated Available Manufacturing 4/04/2025 simvastatin Tablet, film coated 80 mg Current Unavailable Manufacturing 4/04/2025 rabeprazole sodium Tablet, enteric coated 20 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 4/04/2025 ezetimibe Tablet, uncoated 10 mg Current Limited Availability Unexpected increase in consumer demand 4/04/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Unexpected increase in consumer demand 4/04/2025 ezetimibe Tablet, uncoated 10 mg Current Unavailable Manufacturing 4/04/2025 clonidine hydrochloride Tablet 100 microgram Current Unavailable Unexpected increase in consumer demand 4/04/2025 risperidone Tablet, film coated 1 mg Resolved Available Manufacturing 4/04/2025 levothyroxine sodium Tablet .05 mg Current Unavailable Manufacturing 4/04/2025 levothyroxine sodium Tablet .2 mg Current Unavailable Manufacturing 4/04/2025 levothyroxine sodium Tablet .1 mg Current Unavailable Manufacturing 4/04/2025 levothyroxine sodium Tablet .075 mg Current Unavailable Manufacturing 4/04/2025 atorvastatin calcium trihydrate Tablet, film coated 21.688 mg Current Limited Availability Manufacturing 4/04/2025 rivaroxaban Tablet, film coated 20 mg Current Unavailable Manufacturing 4/04/2025 metoprolol tartrate Tablet, uncoated 50 mg Anticipated Available Manufacturing 4/04/2025 sodium chloride Injection, intravenous infusion 9 g/L Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 4/04/2025 sodium chloride Injection, solution 90 mg Current Limited Availability Manufacturing 4/04/2025 midazolam Injection, solution 5 mg/mL Current Limited Availability Unexpected increase in consumer demand 4/04/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~3.14 microgram/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 4/04/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~3.14 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 4/04/2025 ropivacaine hydrochloride~fentanyl citrate Injection, solution 2 mg/mL~6.28 microgram/mL Discontinued Unavailable Commercial Changes / Commercial viability 4/04/2025 fentanyl citrate~ropivacaine hydrochloride Injection, solution 6.28 microgram/mL~2 mg/mL Discontinued Unavailable Commercial Changes / Commercial viability 4/04/2025 propofol Injection, emulsion 10 mg/mL Anticipated Available Manufacturing 4/04/2025 clarithromycin Tablet, film coated 250 mg Current Unavailable Manufacturing 4/04/2025 nizatidine Capsule 150 mg Current Limited Availability Manufacturing 4/04/2025 bupivacaine hydrochloride monohydrate Injection, solution 52.7 mg Current Unavailable Unexpected increase in consumer demand 3/04/2025 gentamicin Injection, solution 80 mg Current Unavailable Manufacturing 3/04/2025 olanzapine pamoate monohydrate Injection, powder for 931 mg Resolved Available Transport / Logistic issues / Storage capacity issues 3/04/2025 olanzapine pamoate monohydrate Injection, powder for 690 mg Resolved Available Transport / Logistic issues / Storage capacity issues 3/04/2025 olanzapine pamoate monohydrate Injection, powder for 483 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/04/2025 anastrozole Tablet, film coated 1 mg Resolved Available Manufacturing 3/04/2025 mycophenolate mofetil Tablet, film coated 500 mg Current Limited Availability Manufacturing 3/04/2025 clonidine hydrochloride Tablet, uncoated 100 microgram Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/04/2025 trandolapril Capsule, hard 1 mg Current Unavailable Manufacturing 3/04/2025 trandolapril Capsule, hard 2 mg Current Unavailable Manufacturing 3/04/2025 trandolapril Capsule, hard 4 mg Current Unavailable Manufacturing 3/04/2025 amlodipine besilate~atorvastatin calcium trihydrate Tablet, film coated 13.88 mg~21.688 mg Resolved Available Manufacturing 3/04/2025 noradrenaline (norepinephrine) acid tartrate monohydrate Injection, concentrated 4 mg Current Limited Availability Manufacturing 3/04/2025 atomoxetine hydrochloride Capsule, hard 45.72 mg Current Unavailable Manufacturing 3/04/2025 dosulepin (dothiepin) hydrochloride Tablet, film coated 75 mg Resolved Available Manufacturing 3/04/2025 acamprosate calcium Tablet, enteric coated 333 mg Resolved Available Unexpected increase in consumer demand 3/04/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~82.725 mg Current Unavailable Manufacturing 3/04/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~41.363 mg Current Unavailable Manufacturing 3/04/2025 ezetimibe~atorvastatin calcium trihydrate Tablet, film coated 10 mg~20.681 mg Current Unavailable Manufacturing 3/04/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 3/04/2025 Semaglutide Injection, solution 1.34 mg/mL Current Limited Availability Unexpected increase in consumer demand 3/04/2025 deferasirox Tablet, film coated 90 mg Anticipated Available Manufacturing 3/04/2025 estradiol~norethisterone acetate~estradiol Drug delivery system, transdermal .78 mg~2.7 mg~.62 mg Current Unavailable Manufacturing 3/04/2025 estradiol Drug delivery system, transdermal .39 mg Current Unavailable Manufacturing 3/04/2025 estradiol Drug delivery system, transdermal 1.56 mg Current Unavailable Manufacturing 3/04/2025 paracetamol Tablet, modified release 665 mg Current Limited Availability Transport / Logistic issues / Storage capacity issues 3/04/2025 tirzepatide Injection, solution 5 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 tirzepatide Injection, solution 7.5 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 tirzepatide Injection, solution 12.5 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 tirzepatide Injection, solution 10 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 tirzepatide Injection, solution 15 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 tirzepatide Injection, solution 2.5 mg Current Unavailable Commercial Changes / Commercial viability 3/04/2025 carboplatin Injection, solution 10 mg/mL Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 3/04/2025 doxorubicin hydrochloride Injection, concentrated 20 mg Anticipated Available Manufacturing 3/04/2025 gemfibrozil Tablet, film coated 600 mg Current Unavailable Manufacturing 3/04/2025 estradiol hemihydrate Drug delivery system, transdermal 3.09 mg Current Limited Availability Unexpected increase in demand due to other sponsors unable to supply 3/04/2025 clonidine hydrochloride Tablet, uncoated 150 microgram Current Limited Availability Unexpected increase in consumer demand 3/04/2025 reboxetine mesilate Tablet, uncoated 5.224 mg Anticipated Available Manufacturing 3/04/2025 betiatide Injection, powder for 1 mg Current Limited Availability Manufacturing 2/04/2025 adrenaline (epinephrine) acid tartrate Injection, solution 1.82 mg/mL Current Unavailable Manufacturing 2/04/2025 sugammadex sodium Injection, solution 217.6 mg Discontinued Unavailable Commercial Changes / Commercial viability 2/04/2025 sugammadex sodium Injection, solution 544 mg Discontinued Unavailable Commercial Changes / Commercial viability 2/04/2025 fentanyl Drug delivery system, transdermal 8.4 mg Resolved Available Unexpected increase in demand due to other sponsors unable to supply 2/04/2025 azithromycin dihydrate Tablet, film coated 524.1 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 2/04/2025 levetiracetam Tablet, film coated 1000 mg Resolved Available Manufacturing 2/04/2025 carbidopa monohydrate~entacapone~levodopa Tablet, film coated 33.75 mg~200 mg~125 mg Current Limited Availability Manufacturing 2/04/2025 hydrochlorothiazide~olmesartan medoxomil~amlodipine besilate Tablet 12.5 mg~20 mg~6.944 mg Resolved Available Manufacturing 2/04/2025 olmesartan medoxomil~amlodipine besilate~hydrochlorothiazide Tablet 40 mg~6.944 mg~12.5 mg Current Limited Availability Manufacturing 2/04/2025 adrenaline (epinephrine) acid tartrate Injection, solution 182 microgram/mL Current Unavailable Manufacturing 2/04/2025 morphine hydrochloride trihydrate Injection, solution 20 mg/mL Resolved Available Manufacturing 2/04/2025 atomoxetine hydrochloride Capsule, hard 91.44 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 2/04/2025 fluorouracil Injection, solution 50 mg/mL Current Unavailable Manufacturing 2/04/2025 emtricitabine~tenofovir disoproxil succinate Tablet, film coated 200 mg~300.6 mg Resolved Available Manufacturing 2/04/2025 deferasirox Tablet, film coated 360 mg Current Unavailable Manufacturing 2/04/2025 enoxaparin sodium Injection, solution 150 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 2/04/2025 heparin sodium Injection, solution 1000 IU/mL Resolved Available Manufacturing 2/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 1/04/2025 fentanyl Drug delivery system, transdermal 16.8 mg Resolved Available Manufacturing 1/04/2025 risedronate sodium Tablet, film coated 35 mg Current Unavailable Manufacturing 1/04/2025 propofol Injection, emulsion 10 g/L Current Limited Availability Transport / Logistic issues / Storage capacity issues 1/04/2025 amlodipine besilate~olmesartan medoxomil~hydrochlorothiazide Tablet 6.944 mg~40 mg~25 mg Resolved Available Manufacturing 1/04/2025 duloxetine hydrochloride Capsule, enteric 67.3 mg Resolved Available Manufacturing 1/04/2025 sodium iodide(131I) Oral Liquid, solution 50 MBq Anticipated Available Manufacturing 1/04/2025 sodium iodide(131I) Capsule, hard 50 MBq Anticipated Available Manufacturing 1/04/2025 fenofibrate Tablet, film coated 145 mg Resolved Available Manufacturing 1/04/2025 emtricitabine~efavirenz~tenofovir disoproxil maleate Tablet, film coated 200 mg~600 mg~300 mg Current Unavailable Manufacturing 1/04/2025 timolol maleate Eye Drops, solution 6.83 mg/mL Current Unavailable Commercial Changes / Commercial viability 1/04/2025 benzathine benzylpenicillin tetrahydrate Injection, suspension 600000 USP Unit Current Unavailable Manufacturing 1/04/2025 rivaroxaban Tablet, film coated 10 mg Current Unavailable Manufacturing 1/04/2025 dasatinib propylene glycol Tablet, film coated 58 mg Resolved Available Manufacturing 1/04/2025 dasatinib propylene glycol Tablet, film coated 81.2 mg Resolved Available Manufacturing 1/04/2025 dasatinib propylene glycol Tablet, film coated 116 mg Resolved Available Manufacturing 1/04/2025 adrenaline (epinephrine) Injection, solution 500 microgram Anticipated Available Manufacturing 1/04/2025 rifampicin Capsule, hard 300 mg Current Unavailable Manufacturing 1/04/2025 sodium iodide(131I) Oral Liquid, solution 1201 MBq Anticipated Available Manufacturing 1/04/2025 sodium pertechnetate(99mTc) Injection, solution 20 GBq Anticipated Available Manufacturing 1/04/2025 bicisate dihydrochloride Injection, powder for .9 mg Current Unavailable Manufacturing 1/04/2025 sodium pertechnetate(99mTc) Injection 370 GBq Anticipated Available Manufacturing 1/04/2025 olanzapine Injection, powder for 10 mg Current Limited Availability Unexpected increase in consumer demand 1/04/2025 clopidogrel hydrogen sulfate Tablet, film coated 97.875 mg Anticipated Available Unexpected increase in demand due to other sponsors unable to supply 1/04/2025 bupivacaine hydrochloride Injection, solution 2.5 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 31/03/2025 amlodipine besilate Tablet, uncoated 7 mg Anticipated Available Manufacturing 31/03/2025 bicalutamide Tablet, film coated 50 mg Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 31/03/2025 venlafaxine hydrochloride Capsule, modified release 169.71 mg Current Unavailable Unexpected increase in demand due to other sponsors unable to supply 31/03/2025 bisoprolol fumarate Tablet 2.5 mg Current Limited Availability Manufacturing 31/03/2025 ondansetron hydrochloride dihydrate Tablet, film coated 9.972 mg Resolved Available Unexpected increase in consumer demand 31/03/2025 finasteride Tablet, film coated 1 mg Anticipated Available Manufacturing 31/03/2025 quetiapine fumarate Tablet, modified release 57.565 mg Anticipated Available Unexpected increase in consumer demand 31/03/2025 raloxifene hydrochloride Tablet, film coated 60 mg Current Unavailable Unexpected increase in consumer demand 31/03/2025 acarbose Tablet 100 mg Resolved Available Manufacturing 31/03/2025 acarbose Tablet 50 mg Resolved Available Manufacturing 31/03/2025 amiodarone hydrochloride Injection, solution 150 mg Current Limited Availability Manufacturing 31/03/2025 tenofovir disoproxil maleate Tablet, film coated 300 mg Current Unavailable Manufacturing 31/03/2025 tenofovir disoproxil maleate~emtricitabine Tablet, film coated 300 mg~200 mg Current Limited Availability Manufacturing 31/03/2025 armodafinil Tablet, uncoated 50 mg Current Limited Availability Manufacturing 31/03/2025 prasugrel Tablet, film coated 5 mg Current Unavailable Manufacturing 31/03/2025 spironolactone Tablet, uncoated 25 mg Current Unavailable Manufacturing 31/03/2025 ropivacaine hydrochloride Injection, solution 2 mg/mL Discontinued Reduction in supply until supply is exhausted Commercial Changes / Commercial viability 31/03/2025
ドイツ
- 2025.04.27
Active ingredients Message type Date of the last message Type of reason Tropicamide Change notification 25.04.2025 Production problem Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 25.04.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 25.04.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 25.04.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 25.04.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 25.04.2025 Other Atorvastatin calcium trihydrate (Ph.Eur.) Change notification 25.04.2025 Other Imatinib mesilate Initial notification 25.04.2025 Other Insulin aspart Initial notification 25.04.2025 Other Insulin aspart Initial notification 25.04.2025 Other Imatinib mesilate Change notification 25.04.2025 Other Tropicamide Change notification 25.04.2025 Production problem Pramipexole dihydrochloride monohydrate Initial notification 25.04.2025 Other Pramipexole dihydrochloride monohydrate Change notification 25.04.2025 Other Pramipexole dihydrochloride monohydrate Change notification 25.04.2025 Other Insulin aspart Change notification 24.04.2025 Other Thioctic acid trometamol salt (1:1) Initial notification 24.04.2025 Other Methylprednisolone Initial notification 23.04.2025 Other Methylphenidate hydrochloride Change notification 23.04.2025 Other Methylphenidate hydrochloride Change notification 23.04.2025 Other Methylphenidate hydrochloride Change notification 23.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 23.04.2025 Other Oxaliplatin Change notification 23.04.2025 Other Epirubicin hydrochloride Initial notification 23.04.2025 Production problem Methyldopa (Ph.Eur.) Initial notification 22.04.2025 Other Olanzapine embonate monohydrate Initial notification 22.04.2025 Production problem Pramipexole dihydrochloride monohydrate Initial notification 22.04.2025 Other Pramipexole dihydrochloride monohydrate Initial notification 22.04.2025 Other Trandolapril; verapamil hydrochloride Initial notification 22.04.2025 Other Methylphenidate hydrochloride Change notification 22.04.2025 Other - 2025.04.21
Active ingredients Message type Date of the last message Type of reason Salbutamol sulfate Initial notification 17.04.2025 Other Timolol maleate Initial notification 17.04.2025 Production problem Hydrocortisone acetate (Ph.Eur.) Initial notification 17.04.2025 Production problem Methylphenidate hydrochloride Change notification 17.04.2025 Production problem Dobutamine hydrochloride Initial notification 17.04.2025 Production problem Spironolactone Change notification 17.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 17.04.2025 Other Ethambutol dihydrochloride Change notification 17.04.2025 Other Solifenacin succinate Change notification 17.04.2025 Other Olanzapine embonate monohydrate Change notification 16.04.2025 Production problem Iobenguan ((123)I) Initial notification 16.04.2025 Other Sodium iodide ((123)I) Initial notification 16.04.2025 Other ((111)In)indium(III) chloride; pentetreotide Initial notification 16.04.2025 Other Poly(styrene-co-divinylbenzene)sulfonic acid-(x:y)-((81)Rb)rubidium salt Initial notification 16.04.2025 Other ((201)Tl)Thallium(I) chloride Initial notification 16.04.2025 Other Procaine hydrochloride Initial notification 16.04.2025 Other ((111)In)indium dihydrogen pentetate Initial notification 16.04.2025 Other ((111)In)Indium(III) chloride Initial notification 16.04.2025 Other Duloxetine hydrochloride Change notification 16.04.2025 Other Vancomycin hydrochloride Initial notification 16.04.2025 Other Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) Initial notification 16.04.2025 Production problem Betamethasone valerate (Ph.Eur.) Change notification 16.04.2025 Other Betamethasone valerate (Ph.Eur.) Change notification 16.04.2025 Other Prednicarbate Initial notification 16.04.2025 Other Betamethasone dipropionate (Ph.Eur.); gentamicin sulphate Initial notification 16.04.2025 Other Amphotericin B Initial notification 16.04.2025 Other Morphine sulphate (Ph.Eur.) Initial notification 16.04.2025 Other Morphine sulphate (Ph.Eur.) Initial notification 16.04.2025 Other Prednicarbate Change notification 15.04.2025 Other Oxytetracycline hydrochloride; prednisolone Initial notification 15.04.2025 Other Lithium carbonate Initial notification 14.04.2025 Production problem Sertraline hydrochloride Change notification 14.04.2025 Other Methyldopa (Ph.Eur.) Initial notification 14.04.2025 Production problem Sertraline hydrochloride Initial notification 14.04.2025 Other Spiramycin Initial notification 14.04.2025 Production problem Cyclopentolate hydrochloride Initial notification 14.04.2025 Production problem Acetylcholine chloride Initial notification 14.04.2025 Production problem Salbutamol sulfate Change notification 14.04.2025 Other Urapidil Change notification 14.04.2025 Other Clomipramine hydrochloride Change notification 14.04.2025 Production problem Esmolol hydrochloride Change notification 14.04.2025 Production problem Calcium acetate monohydrate Initial notification 14.04.2025 Other - 2025.04.14
Active ingredients Message type Date of the last message Type of reason Aprepitant Initial notification 11.04.2025 Other Oxazepam Change notification 11.04.2025 Production problem Azithromycin dihydrate Change notification 11.04.2025 Other Pramipexole dihydrochloride monohydrate Initial notification 11.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 11.04.2025 Production problem Pramipexole dihydrochloride monohydrate Initial notification 11.04.2025 Other Atomoxetine hydrochloride Change notification 11.04.2025 Production problem Linezolid Change notification 11.04.2025 Production problem Galantamine hydrobromide Change notification 11.04.2025 Production problem Rizatriptan benzoate Change notification 11.04.2025 Production problem Mometasone furoate (Ph.Eur.) Change notification 11.04.2025 Production problem Distigmine bromide Initial notification 11.04.2025 Other Naproxen Initial notification 11.04.2025 Other Insulin aspart Change notification 11.04.2025 Other Phenoxymethylpenicillin potassium Change notification 11.04.2025 Other Terazosin hydrochloride dihydrate Initial notification 10.04.2025 Other Fusidic acid (Ph.Eur.) Initial notification 10.04.2025 Production problem Hydromorphone hydrochloride Change notification 10.04.2025 Other Tranexamic acid Change notification 10.04.2025 Other Rosuvastatin calcium (Ph.Eur.) Initial notification 10.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 10.04.2025 Other Oxazepam Change notification 10.04.2025 Other Risperidone Change notification 10.04.2025 Production problem Duloxetine hydrochloride Initial notification 09.04.2025 Other Fludarabine phosphate (Ph.Eur.) Change notification 09.04.2025 Other Paricalcitol Change notification 09.04.2025 Other Doxorubicin hydrochloride Change notification 09.04.2025 Other Calcium acetate Initial notification 09.04.2025 Production problem Calcium acetate hydrate ((with details of the water content (1:x))) Initial notification 09.04.2025 Production problem Dexamethasone; gentamicin sulphate Initial notification 09.04.2025 Production problem Quetiapine fumarate (Ph.Eur.) Initial notification 09.04.2025 Other Methylphenidate hydrochloride Change notification 09.04.2025 Other Solifenacin succinate Change notification 09.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 09.04.2025 Other Ibandronate sodium monohydrate Initial notification 09.04.2025 Other Atenolol; chlorthalidone Initial notification 09.04.2025 Other Fusidic acid (Ph.Eur.) Initial notification 09.04.2025 Other Betamethasone dipropionate (Ph.Eur.); salicylic acid Initial notification 09.04.2025 Other Tacrolimus monohydrate Initial notification 09.04.2025 Other Calcium acetate hydrate ((with details of the water content (1:x))) Initial notification 08.04.2025 Production problem Quetiapine fumarate (Ph.Eur.) Change notification 08.04.2025 Other Phenoxymethylpenicillin potassium Change notification 08.04.2025 Production problem Solifenacin succinate Change notification 08.04.2025 Production problem Fludarabine phosphate (Ph.Eur.) Initial notification 08.04.2025 Production problem Methylphenidate hydrochloride Initial notification 08.04.2025 Other Quetiapine fumarate (Ph.Eur.) Change notification 07.04.2025 Other Sertraline hydrochloride Change notification 07.04.2025 Production problem Isosorbide mononitrate Initial notification 07.04.2025 Production problem Atorvastatin calcium trihydrate (Ph.Eur.) Initial notification 07.04.2025 Production problem - 2025.04.07
Active ingredients Type of reason Message type Date of the last message Memantine hydrochloride Production problem Initial notification 05.04.2025 Rivastigmine hydrogen tartrate Production problem Initial notification 05.04.2025 Sertraline hydrochloride Production problem Initial notification 05.04.2025 Duloxetine hydrochloride Production problem Initial notification 05.04.2025 Azithromycin dihydrate Other Change notification 04.04.2025 Hydromorphone hydrochloride Other Change notification 04.04.2025 Phenoxymethylpenicillin potassium Other Change notification 04.04.2025 Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) Other Initial notification 04.04.2025 Tropicamide Production problem Change notification 04.04.2025 Duloxetine hydrochloride Other Initial notification 04.04.2025 Hydrocortisone Other Change notification 04.04.2025 Calcium folinate hydrate Production problem Change notification 04.04.2025 Phenobarbital Other Change notification 04.04.2025 Lamotrigine Other Change notification 04.04.2025 Teicoplanin Other Change notification 03.04.2025 Methylphenidate hydrochloride Other Initial notification 03.04.2025 Atorvastatin calcium trihydrate (Ph.Eur.) Other Change notification 03.04.2025 Aprepitant Other Change notification 03.04.2025 Methylphenidate hydrochloride Production problem Change notification 03.04.2025 Carbamazepine Other Initial notification 03.04.2025 Articaine hydrochloride; epinephrine hydrogen tartrate/adrenaline hydrogen tartrate Production problem Change notification 03.04.2025 Mepivacaine hydrochloride Production problem Initial notification 03.04.2025 Gentamicin sulphate Production problem Change notification 03.04.2025 Carbamazepine Other Change notification 03.04.2025 Quetiapine fumarate (Ph.Eur.) Other Change notification 03.04.2025 Pramipexole dihydrochloride monohydrate Other Change notification 03.04.2025 Anidulafungin Production problem Initial notification 02.04.2025 Nonacog beta pegol Other Change notification 02.04.2025 Salicylic acid; triamcinolone acetonide Other Initial notification 02.04.2025 Betamethasone dipropionate (Ph.Eur.); salicylic acid Other Change notification 02.04.2025 Triamcinolone acetonide; zinc oxide Other Change notification 02.04.2025 Erythromycin Other Change notification 02.04.2025 Prednicarbate Other Change notification 02.04.2025 Cinacalcethydrochloride Other Change notification 01.04.2025 Spironolactone Other Initial notification 01.04.2025 Rifampicin sodium Other Initial notification 01.04.2025 Haloperidol decanoate Production problem Change notification 01.04.2025 Methylphenidate hydrochloride Other Initial notification 01.04.2025 Fluticasone propionate (Ph.Eur.) Other Change notification 01.04.2025 Atorvastatin calcium trihydrate (Ph.Eur.) Other Initial notification 01.04.2025 Paliperidone palmitate Production problem Change notification 01.04.2025 Methylphenidate hydrochloride Other Initial notification 01.04.2025 Quetiapine fumarate (Ph.Eur.) Production problem Change notification 31.03.2025 Trihexyphenidyl hydrochloride Production problem Change notification 31.03.2025 Ciprofloxacin hydrochloride (1:1) 1 H<2>O Other Change notification 31.03.2025 Atorvastatin-Hemicalcium Other Initial notification 31.03.2025 Atorvastatin calcium trihydrate (Ph.Eur.) Other Initial notification 31.03.2025 Tropicamide Production problem Change notification 31.03.2025 Lamotrigine Other Change notification 31.03.2025 Hydrocortisone acetate (Ph.Eur.) Production problem Initial notification 31.03.2025 Fluorometholone Production problem Change notification 31.03.2025 Acyclovir Production problem Change notification 31.03.2025 Prednisolone acetate Production problem Change notification 31.03.2025 Aprepitant Other Initial notification 31.03.2025
フランス
- 2025.04.27
Ingredients Status Update Specialty cilastatin sodium, imipenem monohydrate, rebactam monohydrate Availability 25/04/2025 Recarbrio 500 mg/500 mg/250 mg, powder for solution for infusion – clarithromycin Available again 25/04/2025 Zeclar 0.5 g, powder for solution for diluted infusion – amoxicillin sodium/potassium (clavulanate de) Out of stock 24/04/2025 Levmentin 1 g/200 mg, powder for solution for injection for infusion (IV) – acebutolol (acebutolol hydrochloride) Out of stock 23/04/2025 Sectral LP 500 mg, extended-release film-coated tablet – maprotiline (hydrochloride) Out of stock 22/04/2025 Ludiomil 25 and 75 mg, film-coated tablet – daptomycin Available again 22/04/2025 Daptomycin Noridem 500 mg, powder for solution for injection/infusion in 10 ml vial – risperidone Supply tension 22/04/2025 Risperidone 0.5 mg, 1 mg, 2 mg 3 mg and 4 mg orodispersible tablet – - 2025.04.21
Ingredients Status Update Specialty naloxegol (oxalate) Out of stock 18/04/2025 Moventig 25 mg, film-coated tablet – glucagon (hydrochloride) Availability 18/04/2025 GlucaGen Kit 1 mg/ml, powder and solvent for solution for injection – methylphenidate (hydrochloride) Supply tension 16/04/2025 Concerta LP, extended-release tablet – dexrazoxane hydrochloride Out of stock 16/04/2025 Savene 20 mg/ml, powder and solvent for solution for diluted infusion – magnesium (pidolate of) Supply voltage 16/04/2025 Maginjectable 0.8 per cent, solution for injection – adrenaline (tartrate) Availability 16/04/2025 Jext 300 micrograms, solution for injection in pre-filled pen – bezafibrate Supply tension 14/04/2025 Befizal 200 mg, film-coated tablet – paliperidone Supply tension 14/04/2025 Paliperidone Teva, prolonged-release suspension for injection – - 2025.04.14
Ingredients Status Update Specialty epoetin beta Supply tension 11/04/2025 NeoRecormon range, solution for injection in pre-filled syringe – methylphenidate (hydrochloride) Supply tension 11/04/2025 Methylphenidate Arrow LP, sustained-release capsule – ornidazole Out of stock 11/04/2025 Tiberal 500 mg, solution for infusion – lenalidomide Available again 11/04/2025 Lenalidomide Mylan, capsule – levothyroxine Supply tension 10/04/2025 TCaps 37.5 micrograms, soft capsule – emtricitabine/tenofovir disoproxil Supply tension 09/04/2025 Speciality based on emtricitabine/tenofovir disoproxil 200 mg/245 mg, film-coated tablet – pregabalin Supply tension 08/04/2025 Lyrica 20 mg/ml, oral solution – Calcium folinate and levofolinate Supply tension 08/04/2025 Calcium folinate 10 mg/ml, solution for injection/ infusion* – Calcium levofolinate including Elvorine * – azithromycin dihydrate Available again 08/04/2025 Zithromax 40 mg/ml children, powder for drinkable suspension – nab paclitaxel Available again 07/04/2025 Pazenir 5 mg/mL, powder for dispersion for infusion – ondansetron Supply tension 07/04/2025 Zophren 2 mg/ml, solution for injection in ampoule (IV) – methotrexate Out of stock 07/04/2025 Methotrexate Teva 10 per cent (5 g/50 mL), solution for injection – - 2025.04.07
Ingredients Status Update Specialty cyanocobalamin Supply tension 04/04/2025 Vitamin B12 Gerda 1000 µg/4 ml, solution for injection (IM) and oral use – cyanocobalamin Availability 04/04/2025 Vitamin B12 Delagrange 1000 micrograms/2 ml, solution for injection (IM) and oral use – amiodarone Supply tension 03/04/2025 Cordarone 150 mg/3 ml, solution for injection ampoule (IV) – amoxicillin Remise à disposition 02/04/2025 Amoxicillin-Clamoxyl all oral forms, all strengths – amoxicillin – clavulanic acid Available again 02/04/2025 Amoxicillin / Clavulanic Acid – Augmentin all oral forms, all strengths – methylphenidate (hydrochloride) Supply tension 02/04/2025 Methylphenidate Arrow LP, sustained-release capsule –
英国
- 2025.04.30
- 2025.04.23
医薬品供給通知:フェンタニル(Durogesic DTrans)パッチ
Durogesic DTransワッペンのすべての強みは、2025年12月まで4月から6月まで(強度によって異なります)在庫切れになります。フェンタニルマトリックスパッチの代替ブランド(フェンシーノ、マトリフェン、メゾラール、オピオデュール、イェメックス)は引き続き利用可能であり、需要の増加に対応できます。
出典:Community Pharmacy England
医薬品供給通知:ガランタミン8mg、16mg、24mgの徐放性カプセル
ガランタミン8mg MRカプセルは、2025年7月下旬まで数量限定で販売されています。MRカプセル16mgは2025年4月中旬から5月下旬まで、MRカプセル24mgは2025年4月下旬から7月下旬まで在庫切れとなります。ガランタミン20mg / 5ml経口液剤無糖のまま入手可能です。
出典:Community Pharmacy England
- 2025.04.17
ADHDの治療薬の処方 (最終更新日:2025年4月7日)
最新情報：
– Matoride XL 54mg Prolonged-release tablets are out of stock.
– Equasym XL 10mg, 20mg and 30mg capsules are out of stock.
– Affenid XL 36mg prolonged release tablets, Delmosart 18mg and 27mg prolonged-release tablets are back in stock.
（坂巻コメント：成分名は、いずれもmethylphenidate hydrochloride。日本では、日薬連2月調査では、限定出荷情報はない。一方、日本でニトロソアミン問題で不足が報告されているアトモキセチン製品は、英国では大半が入手可能となっている。）
- 2025.04.15
医薬品供給のお知らせ:ジルチアゼム(アンジチル® SR)90mg徐放性カプセル
アンジチルSR 90mg MRカプセルは4月末まで在庫切れです。チルディエムリタード90mg徐放性錠剤は引き続き入手可能で、需要の増加に対応できますが、アディゼムSR90mg MRカプセルは対応できません。.
出典:Community Pharmacy England
医薬品供給通知:トリアムシノロンアセトニド10mg / ml(アドコルチル®アンプル)および40mg / ml(ケナログ®バイアル)注射用懸濁液
どちらも販売終了となり、2025年6月上旬までに在庫がなくなり次第終了となる見込みです。利用可能な無認可の供給、およびデキサメタゾンリン酸ナトリウム、コハク酸ヒドロコルチゾンナトリウム、およびコハク酸メチルプレドニゾロンナトリウムと酢酸が利用可能で、需要の増加をサポートできます。
出典:Community Pharmacy England
クラス2医薬品のリコール:Synalar GEL 30g、Synalar GEL 60g、(フルオシノリンアセトニド0.025%)、EL(25)A / 16
Synalar Gel 30gおよび60gのバッチには、ICH制限の2ppmを超えるレベルの残留溶媒(ベンゼン)が含まれていることがわかりました。Reig Jofre UKは、予防措置としてバッチをリコールしています。このリコールは、薬局および卸売業者レベルで行われています。
出典:医薬品・ヘルスケア製品規制庁
- 2025.04.01
Medicine supply notification: Megestrol (Megace) 160mg tablets
2025年4月中旬まで在庫切れ。メドロキシプロゲステロンMedroxyprogesterone (Provera)200mgと400mgの錠剤は引き続き利用可能で、需要の増加を支えることができ、ジェネリック版は4月に発売される予定。
EU
EUの情報はありません。